[针对低氧反应的创新治疗药物的开发]
Kiyotsugu Yoshikawa1, Hiroki Hagimoto2, Eijiro Nakamura2
1Laboratory of Pharmacotherapy, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts.
概括
诺贝尔奖获得者发现了细胞如何感知氧气,这导致了新的药物. 这项关于细胞氧气适应和低氧环境的研究为创新疗法铺平了道路.
科学领域:
- 身体生理学 身体生理学
- 细胞生物学 细胞生物学
- 医学研究 医学研究
背景情况:
- 2019年诺贝尔生理学或医学奖表彰了细胞氧气传感方面的发现.
- 关于细胞如何感知和适应氧气供应的研究是由不同的医学专业推动的.
- 了解低氧环境对于许多生理过程至关重要.
研究的目的:
- 解释细胞氧气感应和适应的生理机制.
- 突出从基础科学到治疗药物开发的翻译性研究之旅.
- 讨论基于氧气传感途径发现的创新药物的开发.
主要方法:
- 关于氧气感应机制的基础研究的审查.
- 对HIF-PH抑制剂和HIF-2抑制剂的发展进行分析.
- 检查促使翻译研究的临床需求.
主要成果:
- 阐明细胞如何感知和适应氧气的可用性.
- 开发新型治疗药物,包括HIF-PH抑制剂和HIF-2抑制剂.
- 展示成功的翻译性研究,将临床需求与药物创新联系起来.
结论:
- 细胞氧传感机制的发现导致了显著的治疗进步.
- 翻译性研究有效地将基本的生理见解转化为针对未满足的临床需求的创新治疗方法.
- 这项获得诺贝尔奖的作品体现了跨学科合作在推动医学科学的力量.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
199
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
199
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Hypoxia
1.0K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
156
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
156


